FDA Greenlights Higher-Dose Wegovy 7.2 mg as Novo Nordisk Fights Back Against Zepbound Dominance The weight-loss drug wars just heated up. The U.S. Food and Drug Administration has approved Novo Nordisk’s higher-dose version of Wegovy — a 7.2-milligram injection — giving the blockbuster semaglutide shot a fresh edge against rival Eli Lilly’s Zepbound. Novo plans … Read more
Trump Indicators Pharmaceutical Tariffs Are Coming, But Shares Rise in Defiance April 9, 2025 – Washington, D.C. – President Donald Trump doubled down on his commerce warfare rhetoric Tuesday night time, declaring at a Nationwide Republican Congressional Committee dinner that “main” tariffs on pharmaceutical imports are imminent, a transfer he insists will “carry drug manufacturing … Read more
[ad_1] The Amgen emblem is displayed exterior Amgen headquarters in Thousand Oaks, California, on Might 17, 2023. Amgen on Wednesday stated it has began two vital late-stage trials for its experimental weight reduction injection MariTide, one other step in its bid to enter the booming weight problems drug market. “We’re delighted to share that these … Read more
Biotechnology giant Amgen Inc. has announced a major investment exceeding $600 million to construct a state-of-the-art research and development (R&D) center at its global headquarters in Thousand Oaks, California. This move underscores the company’s commitment to advancing scientific innovation amid a shifting U.S. pharmaceutical landscape, where domestic investments are surging in response to potential trade … Read more